Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$626B
| $885M | 1.24% |
7,102,700
+3,679,600
| +107% | +$440M |
|
2
NetEase
NTES
$81.9B
| $645M | 0.9% |
11,348,500
+1,279,000
| +13% | +$68.9M |
|
3
Mastercard
MA
$492B
| $591M | 0.83% |
5,252,700
-388,700
| -7% | -$42.6M |
|
|
NVO
4
Novo Nordisk
NVO
$207B
| $563M | 0.79% |
32,818,400
+4,926,600
| +18% | +$85.8M |
|
5
Humana
HUM
$44.8B
| $555M | 0.78% |
2,691,700
+1,231,400
| +84% | +$255M |
|
6
Gilead Sciences
GILD
$168B
| $523M | 0.73% |
7,707,248
+2,432,300
| +46% | +$171M |
|
7
Colgate-Palmolive
CL
$73.6B
| $501M | 0.7% |
6,849,600
-1,604,000
| -19% | -$112M |
|
8
PepsiCo
PEP
$189B
| $486M | 0.68% |
4,343,800
+2,067,338
| +91% | +$222M |
|
|
9
Merck
MRK
$322B
| $468M | 0.65% |
+7,716,460
| New | +$468M |
|
10
NVIDIA
NVDA
$5.27T
| $435M | 0.61% |
159,623,720
+35,835,720
| +29% | +$95.4M |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $397M | 0.55% |
3,111,482
+268,700
| +9% | +$33.7M |
|
12
Amgen
AMGN
$224B
| $396M | 0.55% |
2,413,445
+634,800
| +36% | +$105M |
|
13
Domino's
DPZ
$11.8B
| $393M | 0.55% |
2,130,700
+517,200
| +32% | +$92.6M |
|
14
Crown Castle
CCI
$31.3B
| $378M | 0.53% |
3,998,603
+1,043,700
| +35% | +$93.4M |
|
15
Walmart Inc
WMT
$901B
| $364M | 0.51% |
15,130,200
+3,252,900
| +27% | +$74.9M |
|
16
Cboe Global Markets
CBOE
$29.5B
| $362M | 0.51% |
4,467,300
+81,200
| +2% | +$6.35M |
|
|
17
Booking.com
BKNG
$160B
| $358M | 0.5% |
+5,029,975
| New | +$332M |
|
18
VeriSign
VRSN
$26B
| $358M | 0.5% |
4,104,376
-159,000
| -4% | -$13.2M |
|
|
19
IBM
IBM
$225B
| $352M | 0.49% |
+2,116,790
| New | +$355M |
|
20
Bristol-Myers Squibb
BMY
$130B
| $352M | 0.49% |
6,468,000
+5,871,000
| +983% | +$322M |
|
|
RAI
21
DELISTED
Reynolds American Inc
RAI
| $348M | 0.49% |
5,514,535
+5,503,235
| +48,701% | +$331M |
|
22
Costco
COST
$419B
| $317M | 0.44% |
1,891,800
-927,913
| -33% | -$156M |
|
23
Meta Platforms (Facebook)
META
$1.53T
| $313M | 0.44% |
2,201,800
+2,141,800
| +3,570% | +$286M |
|
24
Sherwin-Williams
SHW
$88.5B
| $298M | 0.42% |
2,885,700
+1,907,700
| +195% | +$192M |
|
25
American Electric Power
AEP
$67.3B
| $294M | 0.41% |
4,383,800
+496,200
| +13% | +$32.1M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.